2021 TDDW
Symposium (X) STRATEGIES TO IMPROVE OUTCOME FOR GASTRIC CANCER IN TAIWAN
DIFFERENCES IN THE SURVIVAL OF GASTRIC CANCER PATIENTS BETWEEN TAIWAN AND OTHER COUNTRIES Yan-Shen Shan College of Medicine, National Cheng Kung University, Tainan, Taiwan Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan Department of Surgery, National Cheng Kung University Hospital, Tainan, Taiwan After eradication of HP in Taiwan, the incidence of gastric cancer reached a lower plateau. The new diagnosed gastric cancer patients are around 3800people/ year since 2008. The crude incidence rate is 12.18/105 in male and 6.76/105 in female. Though different discipline expert treated patients carefully, the 5-year survival of gastric cancer patients is still lower than eastern Asian countries about 10%. The reasons contribute to the modest survival of Taiwan gastric cancer patients should be explored honestly. After investigated the causes, there are three reasons should be discussed deeply:
1.
2.
3.
No screening project in Taiwan, which caused 60% Taiwan gastric cancer patients was diagnosed at stage III/IV. Too many hospitals jointed the cancer patient program rapidly, increased from 50 hospitals to 92 hospitals in 5 years. Insufficient experience in diagnosis and surgical resection will increase morbidity and mortality during treatment. Health insurance payment of DOH for advanced stage gastric cancer patients is not enough, only first line drugs and one second line drug. It will reduce the chance of patients to receive salvage chemotherapy.
63
